Citation Impact

Citing Papers

Single-Molecule Imaging of an in Vitro -Evolved RNA Aptamer Reveals Homogeneous Ligand Binding Kinetics
2009 StandoutNobel
Accurate SHAPE-directed RNA structure determination
2008
Strong Correlation between SHAPE Chemistry and the Generalized NMR Order Parameter ( S 2 ) in RNA
2008
Transferrin receptor targeting by de novo sheet extension
2021 StandoutNobel
Structural inference of native and partially folded RNA by high-throughput contact mapping
2008 StandoutNobel
Automated de novo prediction of native-like RNA tertiary structures
2007 StandoutNobel
C2′-endo nucleotides as molecular timers suggested by the folding of an RNA domain
2009
Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC) - gastrointestinal cancer group
2008
Distinct contributions of KH domains to substrate binding affinity of Drosophila P-element somatic inhibitor protein
2006 StandoutNobel
Offsetting the impact of smoking and e-cigarette vaping on the cerebrovascular system and stroke injury: Is Metformin a viable countermeasure?
2017
Csy4 relies on an unusual catalytic dyad to position and cleave CRISPR RNA
2012 StandoutNobel
Gastric cancer
2016 Standout
Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer
2001
Control of somatic tissue differentiation by the long non-coding RNA TINCR
2012 StandoutNature
Treatment of patients with advanced gastric carcinoma with a 5-fluorouracil-based or a cisplatin-based regimen
1998
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
2006 Standout
Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trial
2010
Strategies for RNA folding and assembly
2004
A randomised phase II study of combination chemotherapy with epirubicin, cisplatin and capecitabine (ECX) or cisplatin and capecitabine (CX) in advanced gastric cancer
2010
Predicting and Modeling RNA Architecture
2010
Distinct sites of phosphorothioate substitution interfere with folding and splicing of the Anabaena group I intron
2004
Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial
2010
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Beyond kinetic traps in RNA folding
2001
Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial
2004
Unconventional miR-122 binding stabilizes the HCV genome by forming a trimolecular RNA structure
2013 StandoutNobel
Ligand-regulated oligomerization of β2-adrenoceptors in a model lipid bilayer
2009 StandoutNobel
Phase II studies of BBR3464, a novel tri-nuclear platinum complex, in patients with gastric or gastro-oesophageal adenocarcinoma
2004
Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START)
2013
Esophageal Cancer
2003 Standout
Mg2+-dependent folding of a Diels-Alderase ribozyme probed by single-molecule FRET analysis
2007
The linkage between magnesium binding and RNA folding 1 1Edited by B. Honig
2002
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
Atomic accuracy in predicting and designing noncanonical RNA structure
2010 StandoutNobel
Two RNA-binding motifs in eIF3 direct HCV IRES-dependent translation
2013 StandoutNobel
Fanconi Anemia Repair Pathway Dysfunction, a Potential Therapeutic Target in Lung Cancer
2014
Two Distinct Binding Modes of a Protein Cofactor with its Target RNA
2006
Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study
2009
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
2015 Standout
Efficacy and tolerability of chemotherapy in elderly patients with advanced oesophago-gastric cancer: A pooled analysis of three clinical trials
2006
Mind the gap: A survey of how cancer drug carriers are susceptible to the gap between research and practice
2013
Oesophageal carcinoma
2013 Standout
Maximizing RNA folding rates: A balancing act
2000
Unwinding RNA's secrets: advances in the biology, physics, and modeling of complex RNAs
2008
A Phase II Study of Epirubicin, Cisplatin and Capecitabine Combination Chemotherapy in Patients with Metastatic or Advanced Gastric Cancer
2005
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
High-Throughput SHAPE and Hydroxyl Radical Analysis of RNA Structure and Ribonucleoprotein Assembly
2009
Insights into RNA structure and function from genome-wide studies
2014 StandoutNobel
Hypoxia-enhanced Blood-Brain Barrier Chip recapitulates human barrier function and shuttling of drugs and antibodies
2019
Visualization of the Hybrid State of tRNA Binding Promoted by Spontaneous Ratcheting of the Ribosome
2008 StandoutNobel
Metal ions and RNA folding: a highly charged topic with a dynamic future
2005
Crystal Structure of the HCV IRES Central Domain Reveals Strategy for Start-Codon Positioning
2011 StandoutNobel
A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction
2010
Chemical biology at the crossroads of molecular structure and mechanism
2005 StandoutNobel
Impact of chemotherapy on quality of life in patients with metastatic esophagogastric cancer
2010
Structural Roles of Monovalent Cations in the HDV Ribozyme
2007 StandoutNobel
Induction of innate immune genes in brain create the neurobiology of addiction
2011
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
RNA Folding: Thermodynamic and Molecular Descriptions of the Roles of Ions
2008
Hepatitis C virus 3′UTR regulates viral translation through direct interactions with the host translation machinery
2013 StandoutNobel
Effects of magnesium ions on the stabilization of RNA oligomers of defined structures
2002
The chemical repertoire of natural ribozymes
2002 StandoutNatureNobel
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
2008 Standout
Visualizing induced fit in early assembly of the human signal recognition particle.
2001
A practical guide to single-molecule FRET
2008 Standout
The status of platinum anticancer drugs in the clinic and in clinical trials
2010 Standout
Challenges in first line chemotherapy and targeted therapy in advanced gastric cancer
2014
The Intestinal Microbiota Affect Central Levels of Brain-Derived Neurotropic Factor and Behavior in Mice
2011 Standout
Worldwide trends in gastric cancer mortality (1980–2011), with predictions to 2015, and incidence by subtype
2014
Modeling nucleic acids
2012 StandoutNobel
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Quantitative studies of ribosome conformational dynamics
2007 StandoutNobel
Structure and Dynamics of a Processive Brownian Motor: The Translating Ribosome
2010 StandoutNobel
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
The side effects of platinum-based chemotherapy drugs: a review for chemists
2018 Standout
Modeling and automation of sequencing-based characterization of RNA structure
2011 StandoutNobel
Structural and Energetic Analysis of Metal Ions Essential to SRP Signal Recognition Domain Assembly
2002 StandoutNobel
S-1 plus oxaliplatin vs. S-1 as first-line treatment in patients with previously untreated advanced gastric cancer: a randomized phase II study
2013
Multiplexed RNA structure characterization with selective 2′-hydroxyl acylation analyzed by primer extension sequencing (SHAPE-Seq)
2011 StandoutNobel
Single-Molecule RNA Science
2005
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Chemotherapy for advanced gastric cancer
2017 Standout
Maternal Plasma RNA Sequencing for Genome-Wide Transcriptomic Profiling and Identification of Pregnancy-Associated Transcripts
2014
Clustering to identify RNA conformations constrained by secondary structure
2011 StandoutNobel
Modeling and design by hierarchical natural moves
2012 StandoutNobel
Classification of Intrinsically Disordered Regions and Proteins
2014 Standout
Assembly of core helices and rapid tertiary folding of a small bacterial group I ribozyme
2003
RNA Catalysis in Model Protocell Vesicles
2005 StandoutNobel
Time-resolved RNA SHAPE chemistry: quantitative RNA structure analysis in one-second snapshots and at single-nucleotide resolution
2009
RNA-guided assembly of Rev-RRE nuclear export complexes
2014 StandoutNobel
Assembly of an Active Group II Intron−Maturase Complex by Protein Dimerization
2004 StandoutNobel
Structural Insights Into the Signal Recognition Particle
2004 StandoutNobel
Coat Protein Activation of Alfalfa Mosaic Virus Replication Is Concentration Dependent
2005
Ions and RNA Folding
2005
Combination Chemotherapy with 5-Fluorouracil and Heptaplatin as First-line Treatment in Patients with Advanced Gastric Cancer
2004

Works of Amy Webb being referenced

Profiling Solute Carrier Transporters in the Human Blood–Brain Barrier
2013
A collapsed state functions to self-chaperone RNA folding into a native ribonucleoprotein complex.
2001
A collapsed non-native RNA folding state.
2000
Assessment of FANCD2 nuclear foci formation in paraffin-embedded tumors: a potential patient-enrichment strategy for treatment with DNA interstrand crosslinking agents
2012
Whole transcriptome RNA-Seq allelic expression in human brain
2013
Protein-dependent transition states for ribonucleoprotein assembly
2001
The Investigation into CYP2E1 in Relation to the Level of Response to Alcohol Through a Combination of Linkage and Association Analysis
2010
First demonstration of anti-lymphoma activity of BCL-2 antisense molecule-G3139; Results of phase I/IIA clinical trial
1997
Rankless by CCL
2026